NCT04393428View on ClinicalTrials.gov

Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

June 1, 2020

Study Completion Date

June 30, 2020

Conditions
COVID-19Renal Replacement TherapyAcute Kidney Injury
Interventions
OTHER

[TIMP-2]*[IGFBP-7]

\[TIMP-2\]\*\[IGFBP-7\] mesurement in urine sample relicates of COVID-19 patients admitted to the Montpellier University Hospital

Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04393428 - Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) | Biotech Hunter | Biotech Hunter